Old Web
English
Sign In
Acemap
>
Paper
>
Biosimilar Ranibizumab (SB11) vs Reference Ranibizumab-Diving Deeper for Safety and Efficacy-Reply.
Biosimilar Ranibizumab (SB11) vs Reference Ranibizumab-Diving Deeper for Safety and Efficacy-Reply.
2021
Neil M. Bressler
Keywords:
Intensive care medicine
Biosimilar
MEDLINE
Medicine
Ranibizumab
Correction
Source
Cite
Save
Machine Reading By IdeaReader
4
References
1
Citations
NaN
KQI
[]